Breast cancer improvement – an updated quality standard England and Wales People diagnosed with a type of early breast cancer and at risk of the cancer spreading should be offered an Oncotype DX test. This test provides information about genetic makeup of the tumour to help predict its development. This information can be used to…
Families need information about vaccines!
Susanna Esposito, Professor of Paediatrics, University of Milan, Italy and President of WAIDID (World Association for Infectious Diseases), thinks families need more information about safety and efficacy of vaccines, in order to overcome their growing hesitancy towards them. Communication is the key!
Did you take your pills today?
Polypharmacy can lead to many hospital admissions and it is something we can do now for our health! In the U.S. research has shown that nearly 30 % of hospital admissions are caused by patients mixing up or making mistakes with their drug use. Polypharmacy, defined as taking 5 or more associated drugs, is a…
Fruit discovery may provide new treatments
New treatments from Fruit A fruit discovery could provide new treatments for some chronic diseases and their pre conditions ie obesity, type 2 diabetes and cardiovascular disease. • 2 compounds found in red grapes and oranges combined could treat diseases • Improved insulin resistance similar to bariatric surgery but achieved three times faster • More effective…
New tests for pregnancy complication to avoid hospital admission
NHS England and Wales: Nice recommendations on new tests to rule out pregnancy complication and avoid unnecessary hospital admission. In a final guidance, a recommendation for 2 blood tests to help rule-out pre-eclampsia, a potentially life threatening complication affecting as many as one in 16 pregnant women1.NICE recommends the Triage PlGF test (Alere) and the…
More access to reports on adverse reactions on medicines in EU
EMA giving increased access to reports on suspected adverse reactions on medicines authorised in EU The EMA will give increased access to reports on suspected adverse reactions to medicines authorised in the European Union, while guaranteeing that personal data will be fully protected. This results from a revision of Eudra Vigilance Access policy adopted by…
uk: Two eye treatments for serious diabetic eye conditions
Two eye treatments for serious diabetic eye condition – final draft guidance NICE recommended aflibercept solution for injection (Eylea, Bayer Pharma), and dexamethasone intravitreal(i) implant (Ozurdex, Allergan) as possible treatment options for some people with diabetic macular oedema, in two separate pieces of final draft guidance published (2 June). This oedema is a common complication…
uk: Consultation on treatments for spinal arthritis
Consultation on draft guidance recommending treatments for types of arthritis that affecting spine NICE has today published draft guidance on adalimumab (Humira, AbbVie), etanercept (Enbrel, Pfizer), infliximab (Remicade, Merck Sharp & Dohme; Inflectra, Hospira; Remsima, Celltrion), certolizumab pegol (Cimzia, UCB Pharma) and golimumab (Simponi, Merck Sharp & Dohme) – known as TNF-alpha inhibitors – for…
uk: Device avoids surgery for enlarged prostate
Plans to support device that avoids surgery for enlarged prostate glands. A new device to relieve urinary tract problems caused by enlarged prostate glands in men is the focus of NICE draft guidance that opens for consultation (Friday 29 May 2015). Views on its draft medical technology guidance – provisionally recommending the UroLift system for treating…
Codeine restriction with children under 12 years old
Codeine not to be used for coughs and colds in children under 12 The Coordination Group for Mutual Recognition and Decentralised Procedures – Human (CMDh)1 agreed by consensus new measures to minimise the risk of serious side effects, including breathing problems, with codeine-containing medicines when used for cough and cold in children. As a result…